Corrections to Rational Modification of a Candidate Cancer Drug for

Corrections to Rational Modification of a Candidate Cancer Drug for Use against ... Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Di...
0 downloads 0 Views 568KB Size
J. Med. Chem. 2009, 52, 4979–4979 4979

Corrections to N9-Substituted 2,4-Diaminoquinazolines: Synthesis and Biological Evaluation of Lipophilic Inhibitors of Pneumocystis carinii and Toxoplasma gondii Dihydrofolate Reductase [J. Med. Chem. 2008, 51, 6196. DOI: 10.1021/ jm800694g]. Aleem Gangjee,* Ona O. Adair Michelle Pagley, and Sherry F. Queener Page 6195. Figure 1 had errors in the structure of TMP. The correct Figure 1 is shown below.

Figure 1 DOI: 10.1021/jm900938h Published on Web 07/08/2009

Corrections to Rational Modification of a Candidate Cancer Drug for Use against Chagas Disease [J. Med. Chem. 2009, 52, 1639. DOI: 10.1021/jm801313t]. James M. Kraus, Christophe L. M. J. Verlinde, Mandana Karimi, Galina I. Lepesheva, Michael H. Gelb,* and Frederick S. Buckner* Page 1646. The following is the Acknowledgment that was missing in the paper: Acknowledgment. This work was partially supported by an NIH grant to G.I.L. (Grant GM067871). DOI: 10.1021/jm900929t Published on Web 07/17/2009